Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.

Balasubramanian S, Pandranki L, Maupin S, Ramasamy K, Taylor AB, Hart PJ, Baseman JB, Kannan TR.

Cell Microbiol. 2019 Aug;21(8):e13032. doi: 10.1111/cmi.13032. Epub 2019 May 9.

PMID:
30977272
2.

Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity.

Ramasamy K, Balasubramanian S, Manickam K, Pandranki L, Taylor AB, Hart PJ, Baseman JB, Kannan TR.

MBio. 2018 Jan 23;9(1). pii: e01663-17. doi: 10.1128/mBio.01663-17.

3.

NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Segovia JA, Chang TH, Winter VT, Coalson JJ, Cagle MP, Pandranki L, Bose S, Baseman JB, Kannan TR.

Infect Immun. 2017 Dec 19;86(1). pii: e00548-17. doi: 10.1128/IAI.00548-17. Print 2018 Jan.

4.

The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):253-260. doi: 10.1165/rcmb.2017-0006OC.

5.

Mycoplasma pneumoniae and health outcomes in children with asthma.

Wood PR, Kampschmidt JC, Dube PH, Cagle MP, Chaparro P, Ketchum NS, Kannan TR, Singh H, Peters JI, Baseman JB, Brooks EG.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):146-152.e2. doi: 10.1016/j.anai.2017.05.022. Epub 2017 Jun 19.

6.

Regulation of TLR3 Activation by S100A9.

Tsai SY, Segovia JA, Chang TH, Shil NK, Pokharel SM, Kannan TR, Baseman JB, DefrĂȘne J, PagĂ© N, Cesaro A, Tessier PA, Bose S.

J Immunol. 2015 Nov 1;195(9):4426-37. doi: 10.4049/jimmunol.1500378. Epub 2015 Sep 18.

7.

Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma.

Devarajan B, Prakash L, Kannan TR, Abraham AA, Kim U, Muthukkaruppan V, Vanniarajan A.

BMC Cancer. 2015 Apr 28;15:320. doi: 10.1186/s12885-015-1340-8.

8.

Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Becker A, Kannan TR, Taylor AB, Pakhomova ON, Zhang Y, Somarajan SR, Galaleldeen A, Holloway SP, Baseman JB, Hart PJ.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5165-70. doi: 10.1073/pnas.1420308112. Epub 2015 Apr 6.

9.

ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.

Bose S, Segovia JA, Somarajan SR, Chang TH, Kannan TR, Baseman JB.

MBio. 2014 Dec 23;5(6). pii: e02186-14. doi: 10.1128/mBio.02186-14.

10.

Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.

Somarajan SR, Al-Asadi F, Ramasamy K, Pandranki L, Baseman JB, Kannan TR.

MBio. 2014 Aug 19;5(4). pii: e01497-14. doi: 10.1128/mBio.01497-14.

11.

Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice.

Medina JL, Coalson JJ, Brooks EG, Le Saux CJ, Winter VT, Chaparro A, Principe MF, Solis L, Kannan TR, Baseman JB, Dube PH.

PLoS One. 2014 Jul 24;9(7):e102613. doi: 10.1371/journal.pone.0102613. eCollection 2014.

12.

Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.

Kannan TR, Krishnan M, Ramasamy K, Becker A, Pakhomova ON, Hart PJ, Baseman JB.

Mol Microbiol. 2014 Aug;93(3):568-81. doi: 10.1111/mmi.12680. Epub 2014 Jul 10.

13.

Evaluation of changes in tidal volume during mask ventilation following administration of neuromuscular blocking drugs.

Sachdeva R, Kannan TR, Mendonca C, Patteril M.

Anaesthesia. 2014 Aug;69(8):826-31. doi: 10.1111/anae.12677. Epub 2014 May 7. Erratum in: Anaesthesia. 2019 Sep;74(9):1192.

14.

Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis.

Krishnan M, Kannan TR, Baseman JB.

PLoS One. 2013 May 7;8(5):e62706. doi: 10.1371/journal.pone.0062706. Print 2013.

15.

Mycoplasma pneumoniae in children with acute and refractory asthma.

Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB, Brooks EG.

Ann Allergy Asthma Immunol. 2013 May;110(5):328-334.e1. doi: 10.1016/j.anai.2013.01.022. Epub 2013 Feb 23. Erratum in: Ann Allergy Asthma Immunol. 2013 Oct;111(4):309.

16.

Mycoplasma pneumoniae large DNA repetitive elements RepMP1 show type specific organization among strains.

Musatovova O, Kannan TR, Baseman JB.

PLoS One. 2012;7(10):e47625. doi: 10.1371/journal.pone.0047625. Epub 2012 Oct 16.

17.

Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Medina JL, Coalson JJ, Brooks EG, Winter VT, Chaparro A, Principe MF, Kannan TR, Baseman JB, Dube PH.

Am J Respir Cell Mol Biol. 2012 Jun;46(6):815-22. doi: 10.1165/rcmb.2011-0135OC. Epub 2012 Jan 26.

18.

Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Kannan TR, Hardy RD, Coalson JJ, Cavuoti DC, Siegel JD, Cagle M, Musatovova O, Herrera C, Baseman JB.

Clin Infect Dis. 2012 Jan 15;54(2):225-31. doi: 10.1093/cid/cir769. Epub 2011 Nov 3.

19.

Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Kannan TR, Coalson JJ, Cagle M, Musatovova O, Hardy RD, Baseman JB.

J Infect Dis. 2011 Nov 15;204(10):1596-604. doi: 10.1093/infdis/jir557. Epub 2011 Sep 28.

20.

Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments.

Johnson C, Kannan TR, Baseman JB.

PLoS One. 2011;6(7):e22877. doi: 10.1371/journal.pone.0022877. Epub 2011 Jul 29.

21.

Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.

Tagliabue C, Techasaensiri C, Torres JP, Katz K, Meek C, Kannan TR, Coalson JJ, Esposito S, Principi N, Leff R, Baseman JB, Hardy RD.

J Antimicrob Chemother. 2011 Oct;66(10):2323-9. doi: 10.1093/jac/dkr306. Epub 2011 Jul 25.

22.

Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.

Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, Coalson JJ, Baseman JG, Cagle M, Baseman JB.

Chest. 2011 Aug;140(2):401-407. doi: 10.1378/chest.11-0221. Epub 2011 May 26.

23.

Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia.

Muir MT, Cohn SM, Louden C, Kannan TR, Baseman JB.

Chest. 2011 Feb;139(2):305-310. doi: 10.1378/chest.10-1222. Epub 2010 Sep 30.

24.
25.

Molecular cloning, expression, and characterization of a Ca2+-dependent, membrane-associated nuclease of Mycoplasma genitalium.

Li L, Krishnan M, Baseman JB, Kannan TR.

J Bacteriol. 2010 Oct;192(19):4876-84. doi: 10.1128/JB.00401-10. Epub 2010 Jul 16.

26.

Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, Coalson JJ, Baseman JB, Hardy RD.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):797-804. doi: 10.1164/rccm.201001-0080OC. Epub 2010 May 27.

27.

Crystallization of community-acquired respiratory distress syndrome toxin from Mycoplasma pneumoniae.

Pakhomova ON, Taylor AB, Becker A, Holloway SP, Kannan TR, Baseman JB, Hart PJ.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Mar 1;66(Pt 3):294-6. doi: 10.1107/S1744309110000114. Epub 2010 Feb 24.

28.

Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.

Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, Krunkosky TM, Davis A, Hardy RD, Baseman JB.

Mol Microbiol. 2010 Jun 1;76(5):1127-41. doi: 10.1111/j.1365-2958.2010.07092.x. Epub 2010 Feb 28.

29.

Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.

Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, Cantwell AM, Kannan TR, Baseman JB, Dube PH.

PLoS One. 2009 Oct 27;4(10):e7562. doi: 10.1371/journal.pone.0007562.

30.

Characterization of a unique ADP-ribosyltransferase of Mycoplasma penetrans.

Johnson C, Kannan TR, Baseman JB.

Infect Immun. 2009 Oct;77(10):4362-70. doi: 10.1128/IAI.00044-09. Epub 2009 Aug 3. Erratum in: Infect Immun. 2009 Dec;77(12):5710.

31.

Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.

Berg CP, Kannan TR, Klein R, Gregor M, Baseman JB, Wesselborg S, Lauber K, Stein GM.

Liver Int. 2009 Jul;29(6):797-809. doi: 10.1111/j.1478-3231.2008.01942.x.

PMID:
19638108
32.

Amino acid changes in elongation factor Tu of Mycoplasma pneumoniae and Mycoplasma genitalium influence fibronectin binding.

Balasubramanian S, Kannan TR, Hart PJ, Baseman JB.

Infect Immun. 2009 Sep;77(9):3533-41. doi: 10.1128/IAI.00081-09. Epub 2009 Jun 22.

33.

Characterization of a unique ClpB protein of Mycoplasma pneumoniae and its impact on growth.

Kannan TR, Musatovova O, Gowda P, Baseman JB.

Infect Immun. 2008 Nov;76(11):5082-92. doi: 10.1128/IAI.00698-08. Epub 2008 Sep 8.

34.

Remifentanil for supraventricular tachycardia.

Kannan TR, Bose D.

Anaesth Intensive Care. 2008 May;36(3):463-4. No abstract available.

35.

The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin.

Balasubramanian S, Kannan TR, Baseman JB.

Infect Immun. 2008 Jul;76(7):3116-23. doi: 10.1128/IAI.00173-08. Epub 2008 Apr 14.

36.

Genomic analysis reveals Mycoplasma pneumoniae repetitive element 1-mediated recombination in a clinical isolate.

Musatovova O, Kannan TR, Baseman JB.

Infect Immun. 2008 Apr;76(4):1639-48. doi: 10.1128/IAI.01621-07. Epub 2008 Jan 22.

37.
38.

Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae.

Kannan TR, Provenzano D, Wright JR, Baseman JB.

Infect Immun. 2005 May;73(5):2828-34.

39.

The p40* adhesin pseudogene of Mycoplasma bovis.

Thomas A, Linden A, Mainil J, Dizier I, Baseman JB, Kannan TR, Fleury B, Frey J, Vilei EM.

Vet Microbiol. 2004 Dec 9;104(3-4):213-7.

PMID:
15564030
40.

Intravesical lidocaine for formalin-induced suprapubic pain: case report.

Mishra S, Singhal AK, Kannan TR, Bhatnagar S.

Am J Hosp Palliat Care. 2004 Jan-Feb;21(1):58-60.

PMID:
14748525
41.
42.

Propofol for pediatric radiotherapy.

Punj J, Bhatnagar S, Saxena A, Mishra S, Kannan TR, Panigrahi M, Pandey V.

Indian J Pediatr. 2002 Jun;69(6):495-9.

PMID:
12139135
43.

Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.

Kannan TR, Saxena A, Bhatnagar S, Barry A.

J Pain Symptom Manage. 2002 Jan;23(1):60-5.

PMID:
11779670
44.

Tramadol for postoperative shivering: a double-blind comparison with pethidine.

Bhatnagar S, Saxena A, Kannan TR, Punj J, Panigrahi M, Mishra S.

Anaesth Intensive Care. 2001 Apr;29(2):149-54.

45.

Hemolytic and hemoxidative activities in Mycoplasma penetrans.

Kannan TR, Baseman JB.

Infect Immun. 2000 Nov;68(11):6419-22.

46.

Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia.

Kathirvel S, Sadhasivam S, Saxena A, Kannan TR, Ganjoo P.

Anaesthesia. 2000 Sep;55(9):899-904.

47.

Expression of UGA-containing Mycoplasma genes in Bacillus subtilis.

Kannan TR, Baseman JB.

J Bacteriol. 2000 May;182(9):2664-7.

48.

The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.

Sadhasivam S, Saxena A, Kathirvel S, Kannan TR, Trikha A, Mohan V.

Anesth Analg. 1999 Dec;89(6):1340-5.

PMID:
10589605

Supplemental Content

Loading ...
Support Center